Who are Apollomics, Inc.'s major customers?

Apollomics, Inc. (APLM) key customers include: Johnson & Johnson, Johnson & Johnson, CB-THERAPEUTICS-INC, EDDING-GENOR-GROUP-HOLDINGS-LIMITED. View the full customer network at chainsifter.com/chain/APLM.

What sector is Apollomics, Inc. in?

Apollomics, Inc. (APLM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Apollomics, Inc. (APLM): 5 Verified Supply Chain Relationships

0Suppliers

4Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Apollomics, Inc. (APLM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

1Distinct source URLs

2High confidence

0.747Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Apollomics, Inc. Suppliers

No suppliers on recordApollomics, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.

Apollomics, Inc. Customers

Ticker	Name	Confidence	Evidence
JNJ	Johnson & Johnson	72%	y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infringed or are evidenced to infringe other thi…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from APLM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from APLM graph: Reciprocal relationship from JNJ grap…
CB-THERAPEUTICS-INC	CB-THERAPEUTICS-INC	62%	y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infringed or are evidenced to infringe other thi…
EDDING-GENOR-GROUP-HOLDINGS-LIMITED	EDDING-GENOR-GROUP-HOLDINGS-LIMITED	62%	Unless earlier terminated by either party due to the other party’s material breach (subject to specified conditions), the Genor Agreement remains effective until the later of (i) the full performance…

Apollomics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
APLM-DEBT	Debt stack $643,000	90%	Market cache reports total debt of $643,000.

Apollomics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Apollomics, Inc..

Apollomics, Inc. Ownership

Holder	Name	Confidence	Evidence
APLM-OWNER-CITIGROUP-INC	CITIGROUP INC	90%	13F overlay lists CITIGROUP INC as top holder; 4 tracked holders.

Apollomics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
AURA	Aura Biosciences, Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ACIU	AC Immune SA	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ABBV	AbbVie Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
ALC	Alcon Inc.	100.00	2
CRIS	Curis, Inc.	100.00	2

Apollomics, Inc. Supply Chain